The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 09, 2008

Filed:

Sep. 30, 2003
Applicants:

Takashi Nakagawa, Tokyo, JP;

Hiroyuki Ishiwata, Chiba, JP;

Toshiaki Takizawa, Tokyo, JP;

Toru Kanke, Tokyo, JP;

Yasushi Wada, Tokyo, JP;

Junichi Kawagoe, Saitama, JP;

Inventors:

Takashi Nakagawa, Tokyo, JP;

Hiroyuki Ishiwata, Chiba, JP;

Toshiaki Takizawa, Tokyo, JP;

Toru Kanke, Tokyo, JP;

Yasushi Wada, Tokyo, JP;

Junichi Kawagoe, Saitama, JP;

Assignee:

Kowa Company, Ltd., Nagoya-shi, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/43 (2006.01); A61K 38/48 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a composition for prevention and treatment of kidney diseases comprising one or more effective component(s) of a PAR-2 activating agent which is able to activate PAR-2 and a pharmaceutically acceptable carrier. The present invention further relates to a method for prevention and treatment of kidney diseases comprising administration of a composition for prevention and treatment of kidney diseases containing a PAR-2 activating agent which is able to activate PAR-2 to patients suffering from kidney diseases, and also relates to the use of a PAR-2 activating agent which is able to activate PAR-2 for the manufacture of a composition for prevention and treatment of kidney diseases. The present invention furthermore relates to a method for screening an effective ingredient for prevention and treatment of kidney diseases comprising screening of the activating action of the test substance to PAR-2.


Find Patent Forward Citations

Loading…